March 11, 2020 / 9:24 PM / 22 days ago

BRIEF-Dynavax Announces Q4 Loss Per Share Of $0.44

March 11 (Reuters) - Dynavax Technologies Corp:

* DYNAVAX ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.44

* Q4 EARNINGS PER SHARE ESTIMATE $-0.33 — REFINITIV IBES DATA

* ADVANCING EFFORTS TO LEVERAGE DYNAVAX’S VACCINE ADJUVANT CPG 1018 IN PRODUCT CANDIDATES FOR PERTUSSIS AND CORONAVIRUS

* NET PRODUCT REVENUE FOR Q4 2019 WAS $10.6 MILLION, COMPARED TO $3.9 MILLION FOR Q4 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below